GHK-Cu (Glycyl-L-Histidyl-L-Lysine-Copper) is a naturally occurring copper complex that has gained significant attention in dermatology and regenerative medicine research. It is a small, tripeptide found in human plasma, saliva, and urine, and its levels are known to decline with age.
GHK-Cu’s mechanism of action is primarily attributed to its high affinity for copper ions, forming a copper-peptide complex. This complex is involved in various biological processes, including collagen synthesis, wound healing, antioxidant defense, and anti-inflammatory pathways. It also promotes the synthesis of other extracellular matrix components like elastin and glycosaminoglycans.
Clinical and preclinical research has extensively explored GHK-Cu in the context of:
Its multifaceted biological activities make it a subject of considerable interest for cosmetic and therapeutic applications.
GHK-Cu’s regulatory status may vary depending on jurisdiction and current policy. It is widely available in cosmetic formulations. However, its use in more concentrated forms for research or other applications may fall under different regulatory frameworks. Researchers should consult the latest guidelines from regulatory bodies for specific guidance. For a general overview, refer to our U.S. peptide legal status tracker.
Researchers comparing GHK-Cu products often evaluate:
PeptideChecker tracks GHK-Cu product listings across multiple suppliers to help researchers compare availability, pricing, and quality.
Q: What is GHK-Cu primarily used for in research? A: GHK-Cu is extensively studied for its potential roles in skin regeneration, anti-aging, and wound healing.
Q: How is GHK-Cu typically administered in research settings? A: Common administration routes in research include topical application in creams or serums, and in some studies, subcutaneous injection.
Q: Where can I find verified suppliers for GHK-Cu? A: Our supplier comparison tool provides a list of vendors offering GHK-Cu with purity and pricing details.
\n\n